None of the analysts who follow the company, according to FactSet, have a target price above Friday's close of $79.89. The closest is Dan Ives of Wedbush Securities with a $75 target; the lowest is ...
Low-density lipoprotein cholesterol (LDLC), also known as ‘bad cholesterol,’ contributes to plaque buildup in the arteries and causes damage, making it a ‘silent killer’ ...